10th Conference of

CENTRAL EUROPEAN

HEPATOLOGIC

COLLABORATION

Thermal Hotel Visegrád
19th-20th September 2020

On-line transmission of the 10th Conference of Central European Hepatologic Collaboration is organized by

We would like to invite you
to join the Live stream

days
hours
minutes
seconds

PRESENTATIONS

SATURDAY
SUNDAY

 


 


NOW PLAYING
Robert Flisiak, Béla Hunyady, Gábor Horváth
10th CEHC OPENING
NOW PLAYING
Robert Flisiak, Marieta Simonova, Dorota Zarębska-Michaluk, Béla Hunyady
Road to HCV elimination
NOW PLAYING
Ivica Grgurević, Lucija Virović Jukić
NAFLD
NOW PLAYING
Krzysztof Simon
Liver cirrhosis
NOW PLAYING
Jerzy Jaroszewicz, Peter Jarcuska
Hepatitis B
NOW PLAYING
Peter Ferenci, Ivana Knežević Štromar, Petr Hříbek
Future challenges in hepatology
NOW PLAYING
Krzysztof Tomasiewicz, Monika Pazgan-Simon, István Tornai
Long term consequencses of HCV treatment
NOW PLAYING
Mihály Makara, Mária Dudás
MSD symposium
NOW PLAYING
Robert Flisiak, Gábor Horváth, Béla Hunyady
CLOSING REMARKS

AGENDA

SATURDAY


16:00
10th CEHC OPENING

16:20

Robert Flisiak MD, PhD

President of Central European Hepatology Collaboration

Department of Infectious Diseases and Hepatology of the Medical University, Białystok (PL)

Béla Hunyady MD, PhD

Chair of 10th Meeting of Central European Hepatology Collaboration

Somogy County Kaposi Mór Teaching Hospital, Kaposvár; University of Pécs; Pécs (HU)

Gábor Horváth MD, MGT

President of the Hepatology Section of the Hungarian Gastroenterology Society

President of the Hepatology Section of the Hungarian Gastroenterology Society,
Buda Hepatology Center, Budapest (HU)

16:20
Road to HCV elimination

17:50

Moderator:

Mihály Makara MD

Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Budapest (HU)

„How close we are to HCV elimination in Central Europe – conclusions from the 9th Conference of CEHC”

Robert Flisiak MD, PhD

Department of Infectious Diseases and Hepatology of the Medical University, Białystok (PL)

„Multistakeholder collaboration for HCV treatment of PWID in Bulgaria”

Marieta Simonova MD, PhD

Military Medical Academy, Sofia (BL)

16:20
Road to HCV elimination

17:50

„Grazoprevir/Elbasvir in HIV/HCV-coinfected compared to HCV-monoinfected patients in real world setting”

Dorota Zarębska-Michaluk MD, PhD

Swietokrzyskie Hospital, Kielce (PL)

„Mandatory HCV screening program for healthcare workers in Hungary”

Béla Hunyady MD, PhD

Somogy County Kaposi Mór Teaching Hospital, Kaposvár; University of Pécs; Pécs (HU)

Discussion

17:50
NAFLD

18:40

Moderators:

Peter Jarcuska MD, PhD

Pavol Jozef Šafárik University; Kassa (SK)

Gábor Horváth MD

Buda Hepatology Center; Budapest (HU)

„NAFLD in patients with type 2 diabetes: diagnosis and prognosis in real life cohort”

Ivica Grgurević MD, PhD

University Hospital Dubrava, Zagreb (CR)

„Adipokines in insulin resistance and NAFLD”

Lucija Virović Jukić MD, PhD

Croatian Gastroenterology Society; Zagreb (CR)

Discussion

SUNDAY


08:00
Liver cirrhosis

08:25

Moderator:

Krzysztof Tomasiewicz MD, PhD

Medical University of Lublin (PL)

„Liver cirrhosis - safety and risk of antinfectious and immunosupressive therapies”

Krzysztof Simon MD, PhD

Wroclaw Medical University, Wrocław (PL)

Discussion

08:25
Hepatitis B

09:15

Moderator:

Peter Jarcuska MD, PhD

„Soluble immune markers in chronic hepatitis B”

Jerzy Jaroszewicz MD, PhD

Department of Infectious Diseases and Hepatology, Medical; Białystok (PL)

„Chronic infection with hepatitis B virus in Slovakia”

Peter Jarcuska MD, PhD

Pavol Jozef Šafárik University; Kassa (SK)

Discussion

09:15
Future challenges in hepatology

10:25

Moderator:

Béla Hunyady MD, PhD

Somogy County Kaposi Mór Teaching Hospital, Kaposvár; University of Pécs; Pécs (HU)

„Precision Hepatology”

Peter Ferenci MD, PhD

Medical University of Vienna (A)

„Celiac related hepatitis - do we recognize it?”

Ivana Knežević-Štromar MD, PhD

University Hospital Centre Zagreb, Zagreb (CR)

“Blood plasma spectroscopy - promising tool for HCC screening”

Petr Hříbek MD

Department of Internal Medicine of Central Military Hospital and 1st Faculty of Medicine of Charles University in Prague (CZ)

Discussion

10:25
Coffee break, view of the exhibition and posters

10:45
10:45
Long term consequences of HCV treatment

11:55

Moderator:

Robert Flisiak MD, PhD

Department of Infectious Diseases and Hepatology of the Medical University, Bialystok (PL)

„Is any long term impact of cured HCV infection on immune system and extrahepatic manifestations?”

Krzysztof Tomasiewicz MD, PhD

Medical University of Lublin (PL)

„DAA therapy and HCC risk in patients with HCV”

Monika Pazgan-Simon MD, PhD

Hospital Gromkowski Wroclaw, Koszarowa (PL)

„Incidence of malignant disorders in patients with chronic hepatitis C virus infection achieving sustained virologic response following either interferon-based or interferon-free therapy„

István Tornai MD, PhD

University of Debrecen, Debrecen (HU)

Discussion

12:00
MSD SYMPOSIUM

13:00

Moderator:

Mihály Makara MD

„Treat the un-reachable”

Mihály Makara MD

Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Budapest (HU)

„Reach the un-reachable – the necessity of social support”

Mária Dudás MD

National Public Health Center, Budapest (HU)

13:00
CLOSING REMARKS

13:10

Robert Flisiak MD, PhD

Gábor Horváth MD

Béla Hunyady MD, PhD

The agenda may be a subject to change. Please visit the CEHC Conference webpage for the latest version of the agenda by clicking on the link: http://hepatologia.medicongressbudapest.com/konferencia-program-2020/

E-ASK